Accelerate Drug Discovery With Sapio and NVIDIA

Experience the power of AI-driven drug research and discovery with NVIDIA BioNeMo directly in the Sapio Lab Informatics platform.

Get a Demo

AI-Powered Drug Discovery with Sapio and NVIDIA

Traditional drug discovery is slow, fragmented, and inefficient. Scientists must navigate multiple tools and systems that disrupt workflow.

Sapio Sciences seamlessly integrates NVIDIA BioNeMo into its AI-native lab informatics platform, bringing advanced AI-driven molecular modeling and predictive analytics directly into the research workflow. This enables scientists to generate, analyze, and visualize drug candidates in a unified environment, accelerating discovery through in silico simulations and lab-in-the-loop experimentation, ultimately improving research outcomes.

Seamless AI-Powered Research

Within Sapio ELN, researchers can access BioNeMo NIM microservices to rapidly identify and optimize drug candidates using AI-driven molecular modeling, including:

  • DiffDock NIM – Advanced AI docking model for drug-target interactions.
  • AlphaFold2 NIM – Predicts 3D protein structures with high accuracy.
  • MoIMIM NIM – AI-powered design and optimization of small molecules.

In addition, Sapio supports a growing variety of BioNeMo tools, including:

  • GenMol
  • AlphaFold2-Multimer
  • RFdiffusion
  • ProteinMPNN
  • ESM-2 650M
  • Evo 2
  • Evo 2 Protein Design

Why Choose Sapio and NVIDIA?

icon simplify life

Streamline AI adoption

 Rapidly growing suite of AI-tools.

icon describe your reaction parameters

Accelerate target selection and optimization

Identify potential drug candidates faster.

icon find data

Enhance research precision

Supercomputing-scale biomolecular modeling.

icon time consuming data retrieval

Seamless workflow integration

AI tools embedded directly into Sapio ELN.

Endorsed By Industry Leaders

kevin cramer headshot

“By integrating NVIDIA’s BioNeMo models into the Sapio Platform, we’re empowering researchers with cutting-edge in silico AI tools that streamline the drug discovery process, enabling faster identification of promising candidates and expediting the journey from concept to clinical application.”
– Kevin Cramer, Founder, CEO & CTO, Sapio Sciences

Anthony Costa, NVIDIA

“Integrating NVIDIA Clara and BioNeMo into Sapio’s AI-driven platform gives scientists access to cutting-edge generative AI models, transforming pharmaceutical research.”
– Anthony Costa, Head of Life Sciences, NVIDIA

Ready To Transform Your Research?